Glow Lifetech Corp (GLWLF) fair value: what the stock is really worth
We calculate from audited financials what Glow Lifetech Corp is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.
Valuation from Sep 13, 2026. With the latest figures (losses, negative cash flow), a fair value can no longer be calculated.
Watch Glow Lifetech Corp for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 13, 2026.
How to read this chart
59‑month range $0.0203 – $0.3545 · the $0.0281 price screens above the $0.0234 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 13, 2026.
Follow Glow Lifetech in your weekly email
Every Wednesday you see whether Glow Lifetech is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Glow Lifetech Corp., an ingredient technology company, focuses on producing nutraceutical and cannabinoid-based products. It engages in the commercialization of plant-based MyCell technology delivery system; water-soluble ingredients; customized blends; powder-based capsules, and market-ready products, as well as precision-dosed capsules.
Show more
Glow Lifetech Corp., an ingredient technology company, focuses on producing nutraceutical and cannabinoid-based products. It engages in the commercialization of plant-based MyCell technology delivery system; water-soluble ingredients; customized blends; powder-based capsules, and market-ready products, as well as precision-dosed capsules. The company has exclusive North American rights for the production, sale, and distribution rights for the certain micellization technology for cannabis and hemp derived ingredients, curcumin, vitamin K and iron. It also engages in the business of secondary processing of ingredients to produce micellized materials from certain vitamins, nutraceuticals, and cannabis extracts that makes fat-soluble substances available for immediate absorption into the body reach near 100% bioavailability and water compatibility. The company provides its products under MOD and .decimal brand names. Glow Lifetech Corp. was founded in 1988 and is headquartered in Etobicoke, Canada.
Stock analysis
Glow Lifetech Corp (GLWLF) currently trades at $0.0281, while our model-based Fair Value estimate is $0.0234, implying the stock looks roughly 20.1% overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 95/100, which puts the evidence level at low.
Quality & growth
The Quality Score stands at 30/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Glow Lifetech Corp reported revenue of C$2.1M in FY2025 versus C$0 in FY2021. Reported net income was −C$618K in FY2025.
Key figures
Market cap $6.1M · P/S ratio 2.77 · Net margin −30.1% · Return on equity −18.7% · Return on assets (EBIT) −83.4% · Operating margin −11.0% · Revenue (TTM) $2.2M · Revenue growth (YoY) +34.5%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (medium confidence).
What moves the price
The share trades about 36% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −5% fair-value upside, at −17%, GLWLF screens richer than that median.
Fair Value models
Bear $0.0234Fair Value $0.0234Bull $0.0234
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.29/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Biotechnology · 650 stocks
Beats the industry median on 3/8 measures
Overall it trails its industry peers.
Valuation
Quality Score34 · Below median
Fair Value upside−17% · Above median
Profitability
Return on assets−10% · Below median
Net margin (TTM)−24% · Below median
Operating margin (TTM)−11% · Bottom 25%
Growth and dividend
Revenue growth35% · Top 25%
Valuation Multiplesvs Biotechnology median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Glow Lifetech Corp (GLWLF) overvalued or undervalued?
As of Sep 13, 2026, our model estimates a fair value of $0.0234 versus a price of $0.0281, about −17% upside (overvalued).
What is the fair value of GLWLF?
Our model-based fair value for Glow Lifetech Corp is $0.0234 (as of Sep 13, 2026), built from audited fundamentals. The current price: $0.0281.
What is the quality score of GLWLF?
Glow Lifetech Corp has a Quality Score of 30/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Glow Lifetech Corp (GLWLF)?
Our model-based price target is the fair value of $0.0234 (as of Sep 13, 2026) from 1 valuation models. It is a calculation from audited fundamentals, not an analyst target.
What is the Glow Lifetech Corp stock forecast for 2026?
Our models put fair value at $0.0234, about −17% upside versus a price of $0.0281 (overvalued). The calculation is refreshed regularly with new filings.
What is the revenue of Glow Lifetech Corp (GLWLF)?
Glow Lifetech Corp reported trailing-twelve-month revenue of about $2.2M (latest available figure, as of Sep 13, 2026).
What is the intrinsic value of Glow Lifetech Corp (GLWLF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Glow Lifetech Corp it is $0.0234 per share (as of Sep 13, 2026), against a price of $0.0281. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Glow Lifetech Corp stock overvalued or undervalued in 2026?
As of Sep 13, 2026, GLWLF trades above its calculated fair value: price $0.0281, fair value $0.0234, a gap of about −17% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of GLWLF?
No. The price is what the market pays today ($0.0281); the fair value is what the company's own numbers justify ($0.0234). For Glow Lifetech Corp the two are $0.0047 per share apart. That gap is exactly why we show both numbers side by side.
How much is Glow Lifetech Corp worth?
The market values Glow Lifetech Corp at about $6.1M (market capitalisation, as of Sep 13, 2026). Per share that is $0.0281; our models calculate a fair value of $0.0234 per share.
How solid is the balance sheet of Glow Lifetech Corp (GLWLF)?
Balance-sheet figures for Glow Lifetech Corp (as of Sep 13, 2026): return on equity −18.7%. They feed the Quality Score of 30/100, which measures business quality independently of the share price.
How far is GLWLF from its 52-week high?
Glow Lifetech Corp trades at $0.0281, about 36% below its 52-week high of $0.0439 and at the low of $0.0281 (as of Sep 21, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0234 is for.
Which stocks are comparable to Glow Lifetech Corp?
From the same area (Healthcare) we also value Vertex Pharmaceuticals Incorporated, Regeneron Pharmaceuticals, Inc, argenx SE, Samsung Biologics Co, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Glow Lifetech Corp stock attractive at the current price?
The data as of Sep 13, 2026: price $0.0281, calculated fair value $0.0234 (−17%), Quality Score 30/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of GLWLF calculated?
We run Glow Lifetech Corp through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0234, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Glow Lifetech Corp itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Glow Lifetech Corp (GLWLF)?
The closing price on Sep 21, 2026 was $0.0281. Our model-based fair value is $0.0234, about −17% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Glow Lifetech Corp right now?
The price sits above even our optimistic bull case ($0.0234). The favourable scenario is already priced in. Weak quality (30/100) and above fair value at the same time, the margin of safety is missing on both counts. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Glow Lifetech Corp
How large is the market capitalisation of Glow Lifetech Corp (GLWLF)?
The market capitalisation of Glow Lifetech Corp is $6.1M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Glow Lifetech Corp (GLWLF)?
The price-to-sales ratio of Glow Lifetech Corp is 2.77 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Glow Lifetech Corp (GLWLF)?
The net margin of Glow Lifetech Corp is −30.1% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Glow Lifetech Corp (GLWLF)?
The return on equity (ROE) of Glow Lifetech Corp is −18.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Glow Lifetech Corp (GLWLF)?
On an EBIT basis the return on assets of Glow Lifetech Corp is −83.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Glow Lifetech Corp (GLWLF)?
The operating margin of Glow Lifetech Corp is −11.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Glow Lifetech Corp (GLWLF)?
Revenue at Glow Lifetech Corp is growing +34.5% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Glow Lifetech Corp (GLWLF) generate?
The free cash flow of Glow Lifetech Corp is −$118K (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Glow Lifetech Corp (GLWLF) carry?
The net debt of Glow Lifetech Corp is $166K (fiscal year 2023). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Glow Lifetech Corp in the live analysis
One click puts Glow Lifetech Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Thin data
Sep 13, 2026